Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Antimicrob Agents Chemother ; 65(9): e0069221, 2021 08 17.
Artigo em Inglês | MEDLINE | ID: mdl-34152820

RESUMO

Antibiotic combinations, including ceftazidime/avibactam (CAZ/AVI), are frequently employed to combat KPC-producing Klebsiella pneumoniae (KPC-Kp), though such combinations have not been rationally optimized. Clinical KPC-Kp isolates with common genes encoding aminoglycoside-modifying enzymes (AMEs), aac(6')-Ib' or aac(6')-Ib, were used in static time-kill assays (n = 4 isolates) and the hollow-fiber infection model (HFIM; n = 2 isolates) to evaluate the activity of gentamicin, amikacin, and CAZ/AVI alone and in combinations. A short course, one-time aminoglycoside dose was also evaluated. Gentamicin plus CAZ/AVI was then tested in a mouse pneumonia model. Synergy with CAZ/AVI was more common with amikacin for aac(6')-Ib'-containing KPC-Kp but more common with gentamicin for aac(6')-Ib-containing isolates in time-kill assays. In the HFIM, although the isolates were aminoglycoside-susceptible at baseline, aminoglycoside monotherapies displayed variable initial killing, followed by regrowth and resistance emergence. CAZ/AVI combined with amikacin or gentamicin resulted in undetectable counts 50 h sooner than CAZ/AVI monotherapy against KPC-Kp with aac(6')-Ib'. CAZ/AVI monotherapy failed to eradicate KPC-Kp with aac(6')-Ib and a combination with gentamicin led to undetectable counts 70 h sooner than with amikacin. A one-time aminoglycoside dose with CAZ/AVI provided similar killing to aminoglycosides dosed for 7 days. In the mouse pneumonia model (n = 1 isolate), gentamicin and CAZ/AVI achieved a 6.0-log10 CFU/lung reduction at 24 h, which was significantly greater than either monotherapy (P < 0.005). Aminoglycosides in combination with CAZ/AVI were promising for KPC-Kp infections; this was true even for a one-time aminoglycoside dose. Selecting aminoglycosides based on AME genes or susceptibilities can improve the pharmacodynamic activity of the combination.


Assuntos
Ceftazidima , Infecções por Klebsiella , Aminoglicosídeos/farmacologia , Animais , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Compostos Azabicíclicos/farmacologia , Ceftazidima/farmacologia , Combinação de Medicamentos , Genótipo , Infecções por Klebsiella/tratamento farmacológico , Klebsiella pneumoniae/genética , Camundongos , Testes de Sensibilidade Microbiana , beta-Lactamases/genética
2.
Pharm Res ; 38(7): 1247-1261, 2021 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-34117588

RESUMO

PURPOSE: Skin and soft tissue infections are increasingly prevalent and often complicated by potentially fatal therapeutic hurdles, such as poor drug perfusion and antibiotic resistance. Delivery vehicles capable of versatile loading may improve local bioavailability and minimize systemic toxicities yet such vehicles are not clinically available. Therefore, we aimed to expand upon the use of glutathione-conjugated poly(ethylene glycol) GSH-PEG hydrogels beyond protein delivery and evaluate the ability to deliver traditional therapeutic molecules. METHODS: PEG and GSH-PEG hydrogels were prepared using ultraviolet light (UV)-polymerization. Hydrogel loading and release of selected drug candidates was examined using UV-visible spectrometry. Therapeutic molecules and GST-fusion protein loading was examined using UV-visible and fluorescent spectrometry. Efficacy of released meropenem was assessed against meropenem-sensitive and -resistant P. aeruginosa in an agar diffusion bioassay. RESULTS: For all tested agents, GSH-PEG hydrogels demonstrated time-dependent loading whereas PEG hydrogels did not. GSH-PEG hydrogels released meropenem over 24 h. Co-loading of biologic and traditional therapeutics into a single vehicle was successfully demonstrated. Meropenem-loaded GSH-PEG hydrogels inhibited the growth of meropenem-sensitive and resistant P. aeruginosa isolates. CONCLUSION: GSH ligands within GSH-PEG hydrogels allow loading and effective delivery of charged therapeutic agents, in addition to biologic therapeutics.


Assuntos
Antibacterianos/administração & dosagem , Produtos Biológicos/administração & dosagem , Sistemas de Liberação de Medicamentos/métodos , Hidrogéis/química , Infecções por Pseudomonas/tratamento farmacológico , Antibacterianos/farmacocinética , Disponibilidade Biológica , Produtos Biológicos/farmacocinética , Preparações de Ação Retardada/administração & dosagem , Preparações de Ação Retardada/farmacocinética , Liberação Controlada de Fármacos , Farmacorresistência Bacteriana , Quimioterapia Combinada , Glutationa/química , Humanos , Meropeném/administração & dosagem , Meropeném/farmacocinética , Testes de Sensibilidade Microbiana , Polietilenoglicóis/química , Infecções por Pseudomonas/microbiologia , Pseudomonas aeruginosa/efeitos dos fármacos , Dermatopatias Bacterianas
3.
Nanomedicine ; 21: 102059, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31310808

RESUMO

Ultrasmall nanoparticles (NPs, <10 nm) have promise in cancer treatment, yet little is known about how NP physical properties influence penetration through solid tumors. To elucidate the role of NP size and structure, we prepared a series of sub-10 nm poly(amidoamine) (PAMAM) dendrimers and gold NPs (AuNP), and evaluated penetration in multicellular tumor spheroids (MCTS). Smaller generation 2 dendrimers (G2-NH2, 2.9 nm diameter) penetrated 2.5-fold deeper than larger G7-NH2 (8.1 nm) (P = 0.0005). Despite increased accumulation within MCTS, electrostatic cell interactions and ligand (folic acid, FA)-mediated targeting had minimal influence on penetration. NP rigidity played a minor role in penetration, with smaller rigid AuNP (2 nm) penetrating significantly more than larger AuNP (4 nm) (3-fold, P = 0.014; G2-NH2 vs. G4-NH2, 2.8-fold, P = 0.033). Our findings highlight the importance of rational NP design and provide design cues for tailored NP distributions within solid tumors.


Assuntos
Dendrímeros , Sistemas de Liberação de Medicamentos , Ouro , Nanopartículas Metálicas , Neoplasias , Esferoides Celulares , Dendrímeros/química , Dendrímeros/farmacocinética , Dendrímeros/farmacologia , Ouro/química , Ouro/farmacocinética , Ouro/farmacologia , Humanos , Células MCF-7 , Nanopartículas Metálicas/química , Nanopartículas Metálicas/uso terapêutico , Neoplasias/tratamento farmacológico , Neoplasias/metabolismo , Neoplasias/patologia , Esferoides Celulares/metabolismo , Esferoides Celulares/patologia
4.
Sci Rep ; 14(1): 24662, 2024 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-39433768

RESUMO

Carpinus betulus (CB) is becoming increasingly important in the forests of Central Europe and is significantly increasing its proportion in various habitat types. We have analysed how the increase in CB affects soil properties. The study was conducted in the Bialowieza Forest (BF). We monitored the changes in CB cover between 1962 and 2013 on 56 permanent plots and collected samples of the litter sub-horizons and the content of the underlying A horizons for laboratory analyses in 2014. During the study period, there was a significant increase in CB cover in the second tree layer by an average of 17.4 % (±1.8) and in the shrub layer by 3.8 % (±1.0), as well as an increase in species diversity from 41 % in the past to 59 % currently. The C/N ratio of the Oi sub-horizon was 32.0 (±0.9), and NH4+ compounds predominated over NO3-, with all nitrogen forms most closely associated with the C/N ratio. In the Oea sub-horizon, the C/N ratio was 23.4 (±0.4), and the sum of mineralised nitrogen reached 8%, with a clear predominance of NO3-. The characteristic most strongly associated with the increase in CB coverage was the NO3- content in the Oea sub-horizon. The MID analysis confirmed that the change in CB cover was not only significant, but also ecologically important. We suggest that there is a feedback loop in which the generally observed climate changes lead to trees occupying new habitats that supply the forest floor with high quality litter, which in turn affects the soil and promotes the persistence of changes in the species composition of the forest.

5.
J Control Release ; 365: 936-949, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-38070603

RESUMO

Acute bacterial skin and skin structure infections (ABSSSIs) confer a substantial burden on the healthcare system. Local antibiotic delivery systems can provide controlled drug release directly to the site of infection to maximize efficacy and minimize systemic toxicity. The purpose of this study was to examine the antibacterial activity of antibiotic-loaded glutathione-conjugated poly(ethylene glycol) hydrogels (GSH-PEG) against ABSSSIs utilizing an ex vivo porcine dermal explant model. Vancomycin- or meropenem-loaded GSH-PEG hydrogels at 3 different dose levels were loaded over 1 h. Drug release was monitored in vitro under submerged conditions, by the Franz cell diffusion method, and ex vivo utilizing a porcine dermis model. Antibacterial activity was assessed ex vivo on porcine dermis explants inoculated with Staphylococcus aureus or Pseudomonas aeruginosa isolates treated with vancomycin- or meropenem-loaded GSH-PEG hydrogels, respectively. Histological assessment of the explants was conducted to evaluate tissue integrity and viability in the context of the experimental conditions. A dose-dependent release was observed from vancomycin and meropenem hydrogels, with in vitro Franz cell diffusion data closely representing ex vivo vancomycin release, but not high dose meropenem release. High dose vancomycin-loaded hydrogels resulted in a >3 log10 clearance against all S. aureus isolates at 48 h. High dose meropenem-loaded hydrogels achieved 6.5, 4, and 2 log10 reductions in CFU/ml against susceptible, intermediate, and resistant P. aeruginosa isolates, respectively. Our findings demonstrate the potential application of GSH-PEG hydrogels for flexible, local antibiotic delivery against bacterial skin infections.


Assuntos
Antibacterianos , Vancomicina , Animais , Suínos , Antibacterianos/farmacologia , Antibacterianos/química , Hidrogéis/química , Staphylococcus aureus , Meropeném , Materiais Biocompatíveis
6.
ACS Chem Biol ; 9(9): 2014-22, 2014 Sep 19.
Artigo em Inglês | MEDLINE | ID: mdl-24937678

RESUMO

Natural products remain an important source of drug candidates, but the difficulties inherent to traditional isolation, coupled with unacceptably high rates of compound rediscovery, limit the pace of natural product detection. Here we describe a reactivity-based screening method to rapidly identify exported bacterial metabolites that contain dehydrated amino acids (i.e., carbonyl- or imine-activated alkenes), a common motif in several classes of natural products. Our strategy entails the use of a commercially available thiol, dithiothreitol, for the covalent labeling of activated alkenes by nucleophilic 1,4-addition. Modification is easily discerned by comparing mass spectra of reacted and unreacted cell surface extracts. When combined with bioinformatic analysis of putative natural product gene clusters, targeted screening and isolation can be performed on a prioritized list of strains. Moreover, known compounds are easily dereplicated, effectively eliminating superfluous isolation and characterization. As a proof of principle, this labeling method was used to identify known natural products belonging to the thiopeptide, lanthipeptide, and linaridin classes. Further, upon screening a panel of only 23 actinomycetes, we discovered and characterized a novel thiopeptide antibiotic, cyclothiazomycin C.


Assuntos
Actinobacteria/metabolismo , Produtos Biológicos/química , Avaliação Pré-Clínica de Medicamentos/métodos , Actinobacteria/química , Actinobacteria/genética , Aminoácidos/química , Antibacterianos/química , Antibacterianos/farmacologia , Bacteriocinas/química , Biologia Computacional/métodos , Ditiotreitol/metabolismo , Descoberta de Drogas , Etilaminas/química , Espectrometria de Massas , Estrutura Molecular , Família Multigênica , Peptídeos Cíclicos/química , Peptídeos Cíclicos/farmacologia , Reprodutibilidade dos Testes , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Tiazóis/química , Tiazóis/farmacologia , Tioestreptona/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA